CEACAM5 and hepatocellular carcinoma: The most well-characterized promoters of this group include α-fetoprotein (AFP) promoter that is active in fetal liver and hepatocellular carcinomas [29], and carcinoembryonic antigen (CEA) promoter, which is active in a proportion of breast, lung, colorectal and pancreatic cancers.